Telzuit Medical Technologies, Inc. Signs Agreement With Cingular Wireless & Asurion Managed Wireless for Bio-Patch Data Transfe
10 Avril 2006 - 2:00PM
PR Newswire (US)
- Bio-Patch Now Equipped to Transfer Wireless Data on a National
Level - ORLANDO, Fla., April 10 /PRNewswire-FirstCall/ -- Telzuit
Medical Technologies, Inc. (OTC:TZMT) (BULLETIN BOARD: TZMT) (the
"Company" or "Telzuit") announced today that it has signed an
agreement with Cingular Wireless, a joint venture between AT&T
Inc. (NYSE:T) and BellSouth Corporation (NYSE:BLS), for the
cellular transfer of data sent by Telzuit's Bio-Patch PDA to the
Telzuit data center. The soon-to-be-launched Bio-Patch will collect
a 12-Lead ECG from the patient and transfer it to the patient's
Bio-Patch PDA. From there the proprietary PDA will then utilize
Cingular's national footprint to wirelessly transport the patient's
cardiac data to the Telzuit data center in Orlando, Florida. In
addition, Telzuit signed an agreement with Asurion Managed Wireless
for the staging of Bio-Patch PDA hardware, equipment protection and
all related support. Terms of the agreements were not disclosed.
(Photo: http://www.newscom.com/cgi-bin/prnh/20060410/NYM028 )
Warren Stowell, CEO of Telzuit, commented, "These agreements
provide our Bio-Patch platform with wireless monitoring on a
national level and mark an important step in the nationwide
implementation of the Bio-Patch Wireless Holter Monitor System.
Mobile access is a critical function of our Bio-Patch System, and
partnering with a wireless company of Cingular's caliber gives us
great confidence that our patients and physicians will receive
nationwide wireless service of the highest quality." About Telzuit
Medical Technologies, Inc. Telzuit Medical Technologies, Inc. is
dedicated to providing advanced mobile medicine for people
worldwide. The company is in the final stages of launching its
first product, the FDA-approved Bio-Patch Wireless Heart Monitor.
The Bio-Patch is a full 12-lead, completely wireless Holter
monitor, which is new to the marketplace. In conjunction with its
strategic partners, Telzuit is also building its own dedicated
intranet platform to handle several of the products it will be
releasing, including the Bio-Patch. Telzuit is based in Orlando,
Florida. For more information Telzuit, its business model and its
products, please visit the company's website:
http://www.telzuit.com/ . Forward Looking Statement: Except for
factual statements made herein, the information contained in this
press release consists of forward-looking statements that involve
risks and uncertainties, including the effect of changing economic
conditions, competition within the health products industry,
customer acceptance of products, and other risks and uncertainties.
Such forward-looking statements are not guarantees of performance,
and Telzuit results could differ materially from those contained in
such statements. These forward-looking statements speak only as of
the date of this release, and Telzuit undertake no obligation to
publicly update any forward-looking statements to reflect new
information, events or circumstances after the date of this
release. Contact: Telzuit Medical Technologies, Inc. James Tolan
Co-Founder, Telzuit Medical Technologies, Inc. 407-354-1222
Brainerd Communicators, Inc. Jennifer Gery (media) Todd St.Onge
(investors) 212-986-6667
http://www.newscom.com/cgi-bin/prnh/20060410/NYM028
http://photoarchive.ap.org/ DATASOURCE: Telzuit Medical
Technologies, Inc. CONTACT: James Tolan, Co-Founder of Telzuit
Medical Technologies, Inc., +1-407-354-1222; Jennifer Gery (media)
or Todd St.Onge (investors), both of Brainerd Communicators, Inc.,
+1-212-986-6667, for Telzuit Medical Technologies, Inc. Web site:
http://www.telzuit.com/
Copyright
Bellsouth (NYSE:BLS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Bellsouth (NYSE:BLS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Bellsouth Cp (New York Stock Exchange): 0 recent articles
Plus d'articles sur Bellsouth Cp